{
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2231, 
        2254
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2479, 
        2499
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2670, 
        2690
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2318, 
        2345
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2347, 
        2351
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2465, 
        2469
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1739, 
        1768
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2425, 
        2451
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2352, 
        2358
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2470, 
        2476
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 3^9999^MOH|PIMS|CCO|20160504053111|E609C68649120188376C23A02EAA766E35BC2571|ORU^R01|999999999999|P|2.5|||||||||||\nPID|1||Y9999999^^^^CMR^HOSPITAL 3&9999&MOH~Y9999999^^^^MRN^HOSPITAL 3&9999&MOH~9999999999&AD&ON^^^^JHN||XXXXXXXX^XXXXXXXXX^^^^^||99999999|F|||999 XXXXXXXX XXX^^XXXXXXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|||||||||||\nOBR|1||SC3735-16|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||20160401|||57190^XXXX^XXXXXXX^XXXX-XXXXX^^^^||||||||||||20160503|||C|||||||99999^XX-XXXXXXX^XXXX^XXXXXXX XXXXX^^^^|||||||||||||||||||\n\n\n\n\n\n\n\nPath Report.addendum spec\n\nDIAGNOSIS\nLeft breast core biopsy, SC3735-16/A1 (): SEE SYNOPTIC REPORT\nNote: The size of invasive component on the plane of section used for HER2 testing\nis limited. Please consider repeat testing if the morphology seen or excisional\nspecimen is different from the one seen in the biopsy.\nSpecimen\nSpecimen #:          SC3735-16\nSpecimen Type:        Breast Core\nTumour 1\nBlock #:           A1\nTumour Type:         Invasive mucinous carcinoma\nER\n   ER Results:       POSITIVE\n   % Positive:       100%\n   Average Intensity:    Strong\n  \nPgR\n   PgR Results:       POSITIVE\n   % Positive:       100%\n   Average Intensity:    Strong\nHER2 by IHC\n   HER2 IHC Results:    NEGATIVE (SCORE 0)\nMethods\nCold Ischemia and Fixation Times Meet the requirements Specified in the Latest\nVersion of the ASCO/CAP Guidelines: Yes\n   Fixative:          Formalin\n   Primary Antibody - ER:   SP1 (Health Canada approved)\n   Primary Antibody - PgR:   1E2 (Health Canada approved)\n   Primary Antibody - Her2:  4B5 (Health Canada approved)\n\nFor details, please see consultation report B16-932 (dated 18/04/2016) by Dr. Sharon\nNofech-Mozes at HOSPITAL 2.\n\n\nPath report.gross description\n\nA: The specimen is labeled with the patient`s identification, submitted as\n\"ultrasound-guided core biopsy of left breast nodule at 4:00 site\" and consists of 2\ncores and multiple smaller fragments of mucoid and yellowish soft tissue measuring up\nto 1.3 cm in length and 0.2 cm in diameter. The specimen is submitted in toto as\nfollows:\nA1 and A2: One core/block\nA3: Multiple smaller fragments\nIschemic time: Less than 1 hour\nTissue fixation time: 48-72 hours\n\n\nPath report.relevant Hx\n\nLEFT BREAST NODULE AT 4 O'CLOCK, SOLID LOBULATED. BIRADS 4.\n\n\nPath report.final diagnosis\n\nLEFT BREAST CORE BIOPSY:\n- INVASIVE CARCINOMA WITH MUCINOUS DIFFERENTIATION\n\n\nPath report.site of origin\n\nCORE BIOPSY LEFT BREAST\n\n\nPath report.comments\n\nThe case was peer reviewed, the above is a consensus diagnosis.\nBlock A1 will be sent for hormonal biomarkers to HOSPITAL 12, results will be\nreported as an addendum.\n\n\nPath report.comments\n\n1\n\n\n"
}